Skip to content
ReframedNewsLeft · Right · Centered
Quick ReadArchiveAboutSign in
Briefing stories›Business & Markets

Sun Pharma agrees to acquire Organon in an all-cash deal valued at $11.75 billion

Story date · Monday, April 27, 2026Business & MarketsWell-covered

The facts

  • Sun Pharma has agreed to acquire Organon & Co. in an all-cash transaction with an enterprise value of about $11.75 billion, including debt.
  • Under the agreement, Sun Pharma will pay $14 per share and acquire all outstanding shares of Organon.
  • Organon was spun off from Merck in 2021 and focuses on areas including women's health and biosimilars.
  • The acquisition is part of Sun Pharma's effort to expand its global business and strengthen its portfolio in specialty or innovative medicines.
  • Multiple reports describe the transaction as the largest acquisition by an Indian pharmaceutical company or the largest overseas acquisition by an Indian pharmaceutical company.
  • The transaction has been approved by both companies' boards but still requires customary regulatory approvals and approval from Organon shareholders.
  • The companies have said they expect the deal to close in early 2027, subject to those approvals and other closing conditions.

Context

What does Sun Pharma get through this acquisition?

Sun Pharma would gain full ownership of Organon, a New Jersey-based healthcare company formed from Merck's 2021 spinoff that operates in women's health, biosimilars and established medicines Business Standard,CNBC,Hindu.

Why is Sun Pharma pursuing the deal now?

Reuters and other reports say Sun Pharma has been trying to build its higher-margin specialty and innovative medicines business and broaden its global reach, including in areas such as women's health and biosimilars Aol,Yahoo News,mint.

What still has to happen before the acquisition is completed?

The deal is not closed yet: it still needs regulatory clearance, approval from Organon shareholders and satisfaction of other customary closing conditions, with the companies targeting early 2027 for completion India Today,WSJ.

How left and right read it

Left says

What stands out is that a major cross-border deal would bring a company focused on women's health and biosimilars into a larger global strategy centered on specialty or innovative medicines. Because this is such a large transaction and still needs regulatory and shareholder approval, the public-interest question is whether that expansion ultimately strengthens access and patient-focused priorities in those areas.

Right says

This reads primarily as a strategic scale move: Sun Pharma is using an all-cash deal valued at about $11.75 billion, including debt, to expand its global business and strengthen its portfolio. The key issue is whether the transaction clears the required regulatory and shareholder approvals on the expected path to an early 2027 close, because process and execution matter in a deal of this size.

See this differently than someone you know would?

The receipts — 117 sources

Wire services (4)

APThe TelegraphSun Pharma to acquire US-based Organon & Co at $11.75 billio...
ReutersAolSun Pharma to buy US drugmaker Organon for $11.75 billion in...
ReutersYahoo NewsIndia's Sun Pharma to buy US-listed Organon in $11.75 billio...
ReutersReutersIndia's Sun Pharma to buy Organon in $11.75 billion all-cash...

Other coverage (113)

mintSun Pharma's Organon buy took shape over three months of int...
The Times of IndiaGujarat'Sun Pharma to acquire Organon in $11.8bn all-cash de...
Economic TimesSun Pharma to acquire Organon for $11.75 billion in India's ...
NASDAQ Stock MarketStock Market Today, April 27: Organon Shares Surge After Sun...
The Motley FoolStock Market Today, April 27: Organon Shares Surge After Sun...
Economic TimesOrganon gives Sun Pharma scale and reach, but challenge lies...
Economic TimesSun's strong gravity helps India Inc's pull - The Economic T...
@businesslineSun Pharma-Organon deal: Outlook is mixed
Business StandardLack of growth visibility at Organon could cap Sun Pharma's ...
ThePrintIndia's Sun Pharma takes biosimilar leap with $11.75 billion...
Forbes IndiaSun Pharma's $11.75 billion buy: Is the Organon deal valuati...
Rediff.com India Ltd.What Dilip Shanghvi said on Sun Pharma's Organon Buy
Telangana TodaySun Pharma chairman calls Organon deal both happy and anxiou...
Trade BrainsPharma stock jumps 9% after signing $11.75 Bil deal to acqui...
wallstreet:onlineSun Pharma unterzeichnet endgültige Vereinbarung zur Übernah...
MoneyControlHere's what Sun Pharma will be getting out of $11.75-bn Orga...
Yahoo! FinanceIndia's Sun Pharma Plots $12 Billion Organon Buyout For Glob...
Telangana TodaySun Pharma to acquire Organon in USD 11.75 billion deal
FortuneIndiaSun Pharma's $11.75-bn Organon deal to be part cash, largely...
MoneyControlSun Pharma targets rapid deleveraging of balance sheet to di...
cnbctv18.comSun Pharma to use Organon's global reach, keep focus on R&D:...
FirstpostWhat are biosimilars and why Sun Pharma-Organon deal matters
News18Sun Pharma To Acquire Organon For $11.75 Billion: A Look At ...
Asianet News Network Pvt LtdSun Pharma to buy Organon for $11.75B; shares jump over 7 pe...
BlockonomiSun Pharma's $11.75B Acquisition Sends Organon (OGN) Stock S...
Republic WorldMarkets Convinced On US-Iran War Outcome: Stock Market Exper...
wallstreet:onlineMega-Übernahme entfacht Kursfeuerwerk am Pharma-Markt
RTE.ieSun Pharma to buy US drugmaker Organon for $11.75 billion
LatestLYBusiness News | Sun Pharma to Acquire Organon for $11.75 Bil...
Asian News International (ANI)Sun Pharma to acquire Organon for $11.75 Billion in all-cash...
Economic TimesSun Pharma: How a small Kolkata trader became a global buyou...
Yahoo! FinanceSun Pharma Buys New Jersey-Based Organon in $12 Billion Deal
cnbctv18.com'Debt Averse, Not Risk Averse': Dilip Shanghvi on Sun Pharma...
Zee BusinessMega Pharma Deal: Inside Rs 1.11 Lakh-Cr Sun Pharma-Organon ...
India Infoline LtdWhy Sun Pharma is up today? - Reasons explained | India Info...
GoodreturnsSun Pharma's Biggest Global Bet, Buys Organon in $11.75 Bill...
Business StandardSun Pharmaceuticals enters definitive agreement to acquire O...
finanzen.atMilliarden-Übernahme im Pharmasektor: Sun Pharmaceutical gre...
mintSun Pharma acquires Organon: growth engine or debt trap? | S...
mintSun Pharma Buys US-Based Organon For $11.75 Billion | India'...
finanzen.chSun Pharmaceutical To Buy Organon For $11.75 Bln
RTTNewsSun Pharmaceutical To Buy Organon For $11.75 Bln
Free Press JournalSun Pharma Stock Climbs Over 9% After $11 Bn Organon Deal An...
https://www.outlookbusiness.com/Sun Pharma Shares Jump Over 7 Pc; Market Valuation Surges By...
Business StandardSun Pharma to buy Organon for $11.75 bn, enter top 25 global...
cnbctv18.comSun Pharma Dividend Update: What 6.6 lakh retail holders nee...
Markets InsiderSun Pharma to acquire Organon for $14 per share in all-cash ...
MorningstarIndia's Sun Pharma to Buy U.S. Healthcare Company Organon in...
NewsXSun Pharma's Organon Acquisition: Sun Pharma To Acquire US-B...
Barchart.comShareholder Alert: Ademi LLP investigates whether Organon & ...
MoneyControlSun Pharma's Organon deal 'rare and large acquisition', but ...
Rediff.com India Ltd.Sun Pharma's $11.75 Billion Organon Acquisition: A Strategic...
englishBig Pharma Move: Sun Pharma To Acquire Organon In $11.75 Bil...
The Financial ExpressSun Pharma-Organon $11.75 billion deal - 5 'must know' detai...
Business StandardSun Pharma, Dr Reddy's Labs, Alkem Labs: Nifty Pharma rallie...
Business StandardSun Pharma surges post deal to acquire US-based pharmaceutic...
FinimizeSun Pharma's $11.75 Billion Organon Deal Marks A Big Global ...
mintSun Pharma to acquire US drugmaker Organon for $11.75 billio...
India TodaySun Pharma's biggest-ever bet: Why markets cheered the Organ...
News18Sun Pharma shares jump over 7 pc; market valuation surges by...
The Indian ExpressSun Pharma to acquire Organon for $11.75 bn: How this will e...
NewsBytesSun Pharma seals India's biggest overseas acquisition in 20 ...
The Logical IndianSun Pharma's $11.75 Billion Bet on Organon Signals A High-St...
The Times of IndiaSun Pharma Acquisition: Sun Pharma to acquire US-based Organ...
24 News HDIndia's Sun Pharma to buy Organon in $11.75 billion deal
FortuneIndiaSun Pharma shares jump 5% after $11.75 billion Organon acqui...
Economic TimesSun Pharma Set to Buy Organon for $12.5 Billion
Business StandardSun Pharma rallies 6%, top gainer among Sensex stocks; here'...
@businesslineSun Pharma shares surge over 5% on $11.75-billion Organon de...
India TodayDecoding the Sun Pharma $11.75 billion deal: Why the pharma ...
The Business TimesIndia's Sun Pharma to buy US-listed Organon in about US$11.8...
The HinduSun Pharma to acquire U.S. firm Organon in $11.75 billion de...
Indian Television Dot ComSun Pharma to acquire Organon in $11.75 billion deal at $14 ...
The Financial ExpressSun Pharma in global reckoning with daring Organon deal; all...
mintSun Pharma share price rises 5% on acquisition of US-based O...
LatestLYSun Pharma To Acquire Organon in USD 11.75 Billion Deal, Mar...
The Financial ExpressSun Pharma to acquire Organon in $11.75 billion all-cash dea...
VCCircleSun Pharma to acquire US-listed Organon in $11.75-bn deal
India TodaySun Pharma shares jump over 5% after $11.75 billion Organon ...
Economic TimesSun Pharma shares in focus after firm announces $12-billion ...
cnbctv18.comSun Pharma-Organon Deal: Analysts advice what to do with the...
The Times of IndiaIndia Largest Pharma Deals: Sun Pharma to acquire US-listed ...
Social News XYZSun Pharma to acquire US-based Organon in nearly $11.75 bill...
BW BusinessworldSun Pharma To Buy Organon In $11.75 Bn Deal - BW Businesswor...
FortuneIndiaSun Pharma acquires women's health specialist Organon in a $...
Zee NewsSun Pharma to buy US-listed Organon in about $11.8 billion d...
News18Sun Pharma To Acquire Organon In $11.75 billion Deal; Eyes G...
Free Press JournalSun Pharma Targets $12.4 Billion Scale With Organon Acquisit...
FinimizeSun Pharma Buys Organon For $11.8 Billion To Expand In The U...
Pulse 2.0Sun Pharma: $11.75 Billion Organon Acquisition Expands Globa...
CNBCIndian drugmaker Sun Pharma to buy U.S. firm Organon in $11....
FirstpostIndia's Sun Pharma to buy Organon for $11.75 billion, signal...
Economic TimesSun Pharma to buy Organon in $11.75 billion all-cash deal
@businesslineSun Pharma to acquire US-listed Organon in $12 billion deal
The Wall Street JournalSun Pharmaceutical to Acquire Organon Valued at $11.75 Billi...
cnbctv18.comSun Pharma to acquire Organon in an all-cash transaction wor...
Business StandardSun Pharma to acquire US drugmaker Organon in $11.75 billion...
mintSun Pharma's $11.75 billion Organon bet marks India Inc's bi...
Investing.com IndiaIndia's Sun Pharma to acquire US-listed Organon in $11.8 bil...
StockwatchStockwatch
The Montreal GazetteSun Pharma signs Definitive Agreement to Acquire Organon
ForbesIndian Pharma Billionaire Dilip Shanghvi Doubles Down On The...
wallstreet:onlineSun Pharma signs Definitive Agreement to Acquire Organon
Barchart.comSun Pharma signs Definitive Agreement to Acquire Organon
WBOC TV-16Sun Pharma signs Definitive Agreement to Acquire Organon
The Norfolk Daily NewsSun Pharma signs Definitive Agreement to Acquire Organon
Economic TimesET Exclusive | Sun Pharma set to acquire Organon for $12.5 b...
cnbctv18.comSun Pharma nears $12 billion Organon deal; announcement like...
Trade BrainsWill Sun Pharma's $12 Bil Organon Deal and Biosimilars Push ...
BlockonomiOrganon (OGN) Stock Skyrockets 25% on Sun Pharma's $13 Billi...
ETCFO.comSun Pharma looks to outshine rival bids with $13 billion Org...
Economic TimesSun Looks to Outshine Rival Bids with $13 billion Organon Of...
Economic TimesSun Pharma looks to outshine rival bids with $13 billion Org...

A news briefing built to show both sides.

The day’s biggest stories in one short brief, built to show both sides and the competing values behind the headlines. Free in your inbox.

← Earlier in this briefing
Penny Wong to visit Japan, China and South Korea for energy security talks
Australia's foreign minister, Penny Wong, said she will travel this week to Japan, China and South Korea for talks...
International Affairs
Next in this briefing →
U.S. envoy urges Taiwan legislature to advance supplemental defense budget
The top U.S. diplomat in Taiwan, Raymond Greene of the American Institute in Taiwan, urged Taiwan’s opposition-led...
U.S. Politics

Continue Reading

More in Business & Markets

SIPRI says global military spending rose to about $2.89 trillion in 2025

Global military spending reached about $2.89 trillion in 2025, up 2.9% from 2024 and marking an 11th straight annual...

Business & Markets
Related this week

Canada pledges up to C$560 million to Brazilian-led tropical forest fund

Canada pledged up to C$560 million (US$392.5 million) over four years to the Brazilian-led Tropical Forests Forever...

Science & Climate
From this briefing

Trump says Iran’s oil pipelines could fail within days if exports remain blocked

President Donald Trump said in a Fox News interview that Iran has about three days before parts of its oil pipeline...

U.S. Politics
Back to all stories

A news briefing built to show both sides.

The day’s biggest stories in one short brief, built to show both sides and the competing values behind the headlines. Free in your inbox.

ReframedNews

A daily news briefing on the day’s top stories, built to show both sides.

Written by AI from news reporting. We review published briefings. Who writes this →

Navigate

Quick ReadArchiveSettings

Company

AboutHow it worksSkylark CreationsSign InTerms of ServicePrivacy Policy

© 2026 Reframed.News

Made by Skylark Creations